DATE: November 19, 2020
TIME: 7:00am PST
Congenital CMV is the most frequent infectious cause of neonatal malformation in developed nations. Yet, this disease is largely under-recognized by health authorities and the general public. There is now a global movement to improve awareness, prevention and diagnosis to reduce the impact and burden of this disease.
In light of this, congenital CMV diagnostic algorithms have garnered much discussion in the medical science community. Both universal newborn screening and targeted testing have been proposed and explored, with each approach having its own advantages.
This two part presentation will provide an update on universal screening and targeted screening for neonates as well as a discussion on different specimen sample types and their respective clinical utility, which can impact on the overall clinical diagnosis.
- Describe the clinical presentation of congenital CMV
- Understand the difference between universal screening and targeted testing for congenital CMV
- Recognize the difference in diagnostic methods and sample types for congenital CMV testing
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.